Novavax Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones

2025.11.24 22:30

I'm PortAI, I can summarize articles.

Novavax Inc. shares rose 2.47% to $6.63 on Monday, marking the second consecutive day of gains. Despite this increase, the stock remains 42.60% below its 52-week high of $11.55. The NASDAQ Composite Index rose 2.69%, and the Dow Jones Industrial Average increased by 0.44%. Novavax's trading volume was below its 50-day average. Competitors like Johnson & Johnson, Pfizer, and Merck also saw stock increases.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Novavax Inc. (NVAX) advanced 2.47% to $6.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.69% to 22,872.01 and the Dow Jones Industrial Average rising 0.44% to 46,448.27. This was the stock's second consecutive day of gains. Novavax Inc. closed 42.60% short of its 52-week high of $11.55, which the company achieved on January 7th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 1.05% to $206.05, Pfizer Inc. (PFE) rose 0.72% to $25.22, and Merck & Co. Inc. (MRK) rose 2.70% to $100.40. Trading volume (4.1 M) remained 381,258 below its 50-day average volume of 4.5 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-24-25 1730ET